ADAM10 and rheumatoid arthritis: As discussed in the Introduction, ADAM10 sheds both pro- and anti-inflammatory molecules, and a compound-specific shedding inhibition profile could help determine the relative importance of these substrates in RA progression and identify opportunities for safe therapeutic intervention.